1
Paul Edward Aldrich, Argyrios Georgios Arvanitis, Robert Scott Cheeseman, Robert John Chorvat, Thomas Eugene Christos, Paul Joseph Gilligan, Dimitri Emil Grigoriadis, Carl Nicholas Hodge, Paul John Krenitsky, Everett Latham Scholfield, Sang William Tam, Zelda Rakowitz Wasserman: 1N-alkyl-n-arylpyrimidinamines and derivatives thereof. DuPont Pharmaceuticals Company, Robert W Black, Kenneth B Rubin, Kalim S Fuzail, January 29, 2002: US06342503 (66 worldwide citation)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


2
Thomas Eugene Christos, George S Amato, Robert N Atkinson, Maria Graciela Barolli, Lilli Ann Wolf Gouveia, Mark J Suto: Heterocycles as potassium channel modulators. Icagen, Morgan Lewis & Bockius, November 15, 2011: US08058274 (1 worldwide citation)

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment ...


3
Thomas Eugene Christos, George S Amato, Robert N Atkinson, Maria Graciela Barolli, Lilli Ann Wolf Gouveia, Mark J Suto: Heterocycles as potassium channel modulators. Icagen, Richard V Zanzalari, April 30, 2013: US08431608 (1 worldwide citation)

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment ...


4
Thomas Eugene Christos, George S Amato, Robert N Atkinson, Maria Graciela Barolli, Lilli Ann Wolf Gouveia, Mark J Suto: Heterocycles as potassium channel modulators. Icagen, Richard V Zanzalari, April 28, 2015: US09018208

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment ...


5
Thomas Eugene Christos, George S Amato, Robert N Atkinson, Maria Graciela Barolli, Lilli Wolf Gouveia, Mark J Suto: Heterocycles as potassium channel modulators. Icagen, Townsend And Townsend And Crew, March 5, 2009: US20090062290-A1

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment ...


6
Thomas Eugene Christos, George S Amato, Robert N Atkinson, Maria Graciela Barolli, Lilli Ann Wolf Gouveia, Mark J Suto: Heterocycles as potassium channel modulators. Icagen, Townsend And Townsend And Crew, September 23, 2010: US20100240663-A1

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment ...



Click the thumbnails below to visualize the patent trend.